Drugs / Budesonide/Formoterol
last change May 2006 re-read 2 minutes ago

Budesonide/Formoterol

Developed for
asthma
Investigated by
AstraZeneca

Trials 1 · a red edge is where a trial was stopped

20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT00252863 Dec 2004 → May 2006 asthma AstraZeneca Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Budesonide/Formoterol ClinicalTrials.gov intervention name — accepted as the source's own label NCT00252863
Route Inhaled “Budesonide/Formoterol Turbuhaler 160/4.5 µg” NCT00252863